These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1485059)

  • 21. Familial aggregation of idiopathic normal pressure hydrocephalus: novel familial case and a family study of the NPH triad in an iNPH patient cohort.
    McGirr A; Cusimano MD
    J Neurol Sci; 2012 Oct; 321(1-2):82-8. PubMed ID: 22921954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculations for randomised trials including both independent and paired data.
    Yelland LN; Sullivan TR; Price DJ; Lee KJ
    Stat Med; 2017 Apr; 36(8):1227-1239. PubMed ID: 28074483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A note on effective sample size for constructing confidence intervals for the difference of two proportions.
    Liu GF
    Pharm Stat; 2012; 11(2):163-9. PubMed ID: 22337507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control sample size when cases are given in constant ratio stratum-matched case-control studies.
    Nam JM; Fears TR
    Stat Med; 1992 Sep; 11(13):1759-66. PubMed ID: 1485058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale.
    Hopper JL; Carlin JB
    Am J Epidemiol; 1992 Nov; 136(9):1138-47. PubMed ID: 1462973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accounting for expected attrition in the planning of community intervention trials.
    Taljaard M; Donner A; Klar N
    Stat Med; 2007 Jun; 26(13):2615-28. PubMed ID: 17068842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance, Errors, Power, and Sample Size: The Blocking and Tackling of Statistics.
    Mascha EJ; Vetter TR
    Anesth Analg; 2018 Feb; 126(2):691-698. PubMed ID: 29346210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands.
    Nurnberger JI; Wiegand R; Bucholz K; O'Connor S; Meyer ET; Reich T; Rice J; Schuckit M; King L; Petti T; Bierut L; Hinrichs AL; Kuperman S; Hesselbrock V; Porjesz B
    Arch Gen Psychiatry; 2004 Dec; 61(12):1246-56. PubMed ID: 15583116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On group sequential designs comparing two binomial proportions.
    Kepner JL
    J Biopharm Stat; 2010 Jan; 20(1):145-59. PubMed ID: 20077254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analytical method for assessing patterns of familial aggregation in case-control studies.
    Zhao LP; Le Marchand L
    Genet Epidemiol; 1992; 9(2):141-54. PubMed ID: 1639245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship among design parameters for statistical power between continuous and binomial outcomes in cluster randomized trials.
    Chan W
    Psychol Methods; 2019 Apr; 24(2):179-195. PubMed ID: 29975081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of familial aggregation of Parkinson disease and Alzheimer disease.
    Levy G; Louis ED; Mejia-Santana H; Côté L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R; Marder K
    Arch Neurol; 2004 Jul; 61(7):1033-9. PubMed ID: 15262733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint.
    Xie T; Waksman J
    Stat Med; 2003 Sep; 22(18):2835-46. PubMed ID: 12953283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cluster-adjusted sample size algorithm for proportions was developed using a beta-binomial model.
    Fosgate GT
    J Clin Epidemiol; 2007 Mar; 60(3):250-5. PubMed ID: 17292018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bias associated with study protocols in epidemiologic studies of disease familial aggregation.
    Bai Y; Sherman S; Khoury MJ; Flanders WD
    Am J Epidemiol; 2000 May; 151(9):927-37. PubMed ID: 10791566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial clustering of obesity and breast cancer.
    Parent ME; Ghadirian P; Lacroix A
    Genet Epidemiol; 1996; 13(1):61-78. PubMed ID: 8647379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of childhood mortality in family members of men with poor semen quality.
    Hanson HA; Mayer EN; Anderson RE; Aston KI; Carrell DT; Berger J; Lowrance WT; Smith KR; Hotaling JM
    Hum Reprod; 2017 Jan; 32(1):239-247. PubMed ID: 27927843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size calculations for the development of biosimilar products.
    Kang SH; Kim Y
    J Biopharm Stat; 2014; 24(6):1215-24. PubMed ID: 25032735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.